Predictive Oncology completes $344 million private placement to launch Aethir (ATH) treasury strategy

Foresight News reported that Predictive Oncology Inc. announced today that it has conducted two private placement transactions, planning to raise approximately $344 million to support its digital asset treasury strategy, primarily holding the native utility token of the Aethir (ATH) ecosystem.

The transaction overview shows that the company will raise approximately $344.4 million through private investments in public equity (PIPEs), including the issuance of about 66.7 million shares of common stock (or prepaid warrants to purchase common stock) at a price of $0.7751 per share, expected to generate approximately $51.7 million in cash proceeds (“cash PIPE”), as well as prepaid warrants to purchase up to 223.6 million shares of common stock, with the purchase price being the issue price per warrant minus $0.01, expected to exchange for approximately $292.7 million in nominal value, of which $173.3 million is discounted value, involving locked and unlocked Aethir tokens. The prepaid warrants issued in the crypto PIPE will be immediately exercisable upon receipt of shareholder approval by the company. This PIPE transaction is expected to be completed around October 2, 2025, subject to customary closing conditions.

The company plans to use the physical contribution of ATH to support its digital asset treasury strategy, and the remaining net proceeds from the PIPE transaction will be mainly used to acquire ATH on the open market to further support this strategy, as well as for working capital and general corporate purposes.